#      Analyzing Medicare Spending on Drugs with Known Adverse Effects From Enigma Public        #


Millions of people rely on Medicare for healthcare access.  In 2016, Medicare spending accounted for approximately 18% of U.S. GDP (https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet.html), but U.S. healthcare outcomes Attaining better and more cost-effective health outcomes for Americans relying on Medicare is a complicated problem with many facets.  In this project, I attempt to take a modest step toward understanding how we might shift spending away from costly drugs with known adverse effects to reduce negative patient outcomes and spending at the same time.     
